دورية أكاديمية
Resilience in the Face of Pandemic: The Impact of COVID-19 on the Psychologic Morbidity and Health-Related Quality of Life Among Women With Ovarian Cancer.
العنوان: | Resilience in the Face of Pandemic: The Impact of COVID-19 on the Psychologic Morbidity and Health-Related Quality of Life Among Women With Ovarian Cancer. |
---|---|
المؤلفون: | Javellana M; The University of Chicago Medicine, Department of Gynecology/ Obstetrics, Section of Gynecologic Oncology, Chicago, IL., Hlubocky FJ; The University of Chicago Medicine, Department of Gynecology/ Obstetrics, Section of Gynecologic Oncology, Chicago, IL.; Department of Medicine, Section of Hematology/Oncology, MacLean Center for Clinical Medical Ethics, Cancer Research Center, Supportive Oncology Program, Chicago, IL., Somasegar S; The University of Chicago Medicine, Department of Gynecology/ Obstetrics, Section of Gynecologic Oncology, Chicago, IL., Sorkin M; The University of Chicago Medicine, Department of Gynecology/ Obstetrics, Section of Gynecologic Oncology, Chicago, IL., Kurnit KC; The University of Chicago Medicine, Department of Gynecology/ Obstetrics, Section of Gynecologic Oncology, Chicago, IL., Jani I; The University of Chicago Medicine, Department of Gynecology/ Obstetrics, Section of Gynecologic Oncology, Chicago, IL., Stock E; The University of Chicago Medicine, Department of Gynecology/ Obstetrics, Section of Gynecologic Oncology, Chicago, IL., Mills K; The University of Chicago Medicine, Department of Gynecology/ Obstetrics, Section of Gynecologic Oncology, Chicago, IL., Lengyel E; The University of Chicago Medicine, Department of Gynecology/ Obstetrics, Section of Gynecologic Oncology, Chicago, IL., Lee NK; The University of Chicago Medicine, Department of Gynecology/ Obstetrics, Section of Gynecologic Oncology, Chicago, IL. |
المصدر: | JCO oncology practice [JCO Oncol Pract] 2022 Jun; Vol. 18 (6), pp. e948-e957. Date of Electronic Publication: 2022 Feb 24. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: Alexandria, Va. : American Society of Clinical Oncology, [2020]- |
مواضيع طبية MeSH: | COVID-19*/epidemiology , Ovarian Neoplasms*/complications , Ovarian Neoplasms*/epidemiology , Ovarian Neoplasms*/therapy, Aged ; Cross-Sectional Studies ; Female ; Humans ; Longitudinal Studies ; Morbidity ; Pandemics ; Quality of Life/psychology |
مستخلص: | Purpose: The COVID-19 pandemic has created new challenges for ovarian cancer survivors. This study aims to evaluate the psychologic morbidity and alterations in medical care caused by the pandemic. Methods: Advanced-stage ovarian cancer survivors at our institution were contacted for participation in a cross-sectional telephone-based quantitative survey study assessing pandemic-related psychologic morbidity. Psychologic domains using validated measures were explored: health-related quality of life (HRQOL; functional assessment of cancer therapy [FACT-G7]), anxiety (generalized anxiety disorder-7 [GAD7]), depression (Patient Health Questionnarie-2 [PHQ2]), global health Patient-Reported Outcomes Measurement Information System - Global Physical Health/Global Mental Health (PROMIS-GMH/GPH), resilience (brief resilience scale), and loneliness (English Longitudinal Study on Aging). Novel COVID-19 pandemic questions were drawn from a larger survey developed in our department. Results: Fifty-nine percent (61 of 104) of contacted patients completed the survey. One quarter of respondents had high resilience, with only 10% reporting low resilience. Only one patient screened positive for depression, and two for anxiety. Increased loneliness was reported by 43% of respondents. Patients' overall HRQOL was good (median = 21; range = 6-28). Few patients experienced treatment delays, with only four experiencing chemotherapy interruption and two reporting surgical delays. Multiple regression analyses revealed that high FACT-G7 HRQOL was predicted by age > 65 years, high self-reported mental health, high resilience, and being off chemotherapy. Lower COVID-19 concern was predicted by recurrent cancer and high resilience. Conclusion: Despite the far-reaching impact of the COVID-19 pandemic, ovarian cancer survivors' HRQOL has been maintained. Older age, high resilience, high mental health, and being off chemotherapy predicted better HRQOL. Ovarian cancer survivors remain resilient in the face of the pandemic, and the support of clinicians to preserve this invaluable personal resource is critical for well-being. Competing Interests: Fay J. HlubockyThis author is an Associate Editor for JCO Oncology Practice. Journal policy recused the author from having any role in the peer review of this manuscript. Katherine C. KurnitConsulting or Advisory Role: Leap TherapeuticsTravel, Accommodations, Expenses: Clovis Oncology Kathryn MillsConsulting or Advisory Role: Stryker Ernst LengyelStock and Other Ownership Interests: ExelixisResearch Funding: AbbVie, ArsenalBioNo other potential conflicts of interest were reported. |
تواريخ الأحداث: | Date Created: 20220224 Date Completed: 20220614 Latest Revision: 20220620 |
رمز التحديث: | 20221213 |
DOI: | 10.1200/OP.21.00514 |
PMID: | 35201895 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2688-1535 |
---|---|
DOI: | 10.1200/OP.21.00514 |